Salesforce (NYSE:CRM – Free Report) had its price objective lifted by UBS Group from $285.00 to $310.00 in a research note released on Friday morning, Benzinga reports. The brokerage currently has a neutral rating on the CRM provider’s stock. A number of other equities analysts have also recently issued reports on the stock. Raymond James […]